Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve various types of pain, including pain caused by musculoskeletal conditions, osteoarthritis, and rheumatoid arthritis. With a longer half-life than most other NSAIDS, it is a favorable option for those who require once-daily dosing. Meloxicam is available in oral, transdermal, and intr...
Meloxicam is indicated for the symptomatic treatment of arthritis and osteoarthritis. In addition, it is indicated for the pauciarticular and polyarticular course of Juvenile Rheumatoid Arthritis (JRA) in patients aged 2 years old or above. Off-label uses include the treatment of dental or post-surgical pain. In addition to the above, meloxicam has also been...
University of Miami, Miami, Florida, United States
Prisma Health Midlands, Columbia, South Carolina, United States
Emory University Orthopaedic and Spine Hospital, Atlanta, Georgia, United States
Seoul National University Hospital, Seoul, Korea, Republic of
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, Shanghai, China
Institution of Drug Clinical Trials, Beijing, Beijing, China
The University of Texas Health Science Center at Houston, Houston, Texas, United States
Rothman Institute, Philadelphia, Pennsylvania, United States
Clinical Research Site, Seattle, Washington, United States
Rush University Medical Center, Chicago, Illinois, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.